Orion Corporation Orion Pharma Synthon B.V. Synthon Hispania S.L.
PolandAll drugs from this manufacturer
-
The medicine is intended for adult men with prostate cancer that has metastasized to other parts of the body. It works by inhibiting the production of testosterone, which can slow the growth of the tumor.
Dosage form: tablets, film-coated
Active substance Dosage abiraterone acetate 500 mg ATC: L02BX03
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 2.5 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 7.5 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
-
The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC: L04AX04
-
Linorion is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04